This video was published 212 Days 23 Hours 46 Mins ago.
Premium Access: Available NOW Member Access: Available NOW Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.
The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.
Members are encouraged to ask these executives questions through their message boards at Mywallst
Cardiovascular Sciences, Inc. is an advanced medical device company which is developing a novel technology platform to address the problem of post-surgical and post-traumatic adhesions. Adhesions and the complications of adhesions are a significant problem worldwide for a wide range of specialists, including general surgeons, cardiothoracic surgeons, orthopedic, plastic, and ophthalmologic and otolaryngology specialists to name just some of them. In addition, the veterinary field has a tremendous need for a product that can prevent similar problems in a wide variety of animals. The Company's unique materials and processes promise a more cost-effective and decidedly more efficient and capable means to deal with a problem that has been so devastating to so many. Current sponsored research at the University of Central Florida (UCF) and previously at other institutions indicate that The Company is on the right path and progressing well. In addition to the anti-adhesion technology, The Company owns technology in a variety of other areas, including thrombo-resistant coatings, enhanced intra-arterial balloon pumping catheters, cell-engineered vascular tissues, and a method for improved recovery of the heart following cardioplegia. This yields a diversified portfolio with projects in various stages of development. www.cvsciences.org.
Last Trade
0.0600
Volume
3,180
Change
0.00
Shares
n.a.
Change %
+0.00%
Market Cap.
911.50K
Today's High
0.0700
52 Week High
n.a.
Today's Low
0.0600
52 Week Low
n.a.
Bid
n.a. x n.a.
EPS
n.a.
Ask
n.a. x n.a.
P/E Ratio
-0.00667
Open
0.07
Div. Per Share
n.a.
Previous Close
0.06
Exchange
PNK
User Comments
0 Bulls
0 Bears
Be the first to comment on Cardiovascular Sciences, Inc. (Pink Sheets: CVSC)
Teradata Corporation is the world's largest company solely focused on raising intelligence through data warehousing, consulting services and enterprise analytics. Teradata is in more than 60 countries...
Starwood Hotels & Resorts Worldwide, Inc., together with its subsidiaries, operates as a hotel and leisure company worldwide. It primarily operates luxury and upscale full service hotels, retreats, an...
GeneThera, Inc., a development stage biotechnology company, develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms. The co...
Vein Clinics of America, a wholly owned subsidiary of IntegraMed America, Inc.,
Horizon Air, an Alaska Air Group, Inc. company,
Ingen Technologies, Inc.
Featured Company:
